West Pharmaceutical Services(NYSE:WST) announced the earnings results for Fiscal Year 2016 and Q2. The results came in during Pre-market on Jul 28, 2016. Company reported revenue of $388.00M. Analysts estimated a revenue of $384.58M. Earnings per share were $0.59. Analysts had estimated an EPS of $0.56.
West Pharmaceutical Services (WST) made into the market gainers list on Thursdays trading session with the shares advancing 0.67% or 0.54 points. Due to strong positive momentum, the stock ended at $81.5, which is also near the day’s high of $81.86. The stock began the session at $81.16 and the volume stood at 2,77,759 shares. The 52-week high of the shares is $81.86 and the 52 week low is $52.79. The company has a current market capitalization of $5,956 M and it has 7,30,77,552 shares in outstanding.
Several Insider Transactions has been reported to the SEC. On Jun 2, 2016, Daniel Malone (Vice President & Controller) sold 3,950 shares at $74.95 per share price.Also, On May 25, 2016, Thomas W Hofmann (director) sold 2,466 shares at $73.57 per share price.On Mar 2, 2016, Michael A Anderson (Vice President & Treasurer) sold 16,414 shares at $63.60 per share price, according to the Form-4 filing with the securities and exchange commission.
West Pharmaceutical Services Inc. is a manufacturer of components and systems for the packaging and delivery of injectable drugs as well as delivery system components for the pharmaceutical healthcare and consumer products industries. The Company’s products include stoppers and seals for vials prefillable syringe components and systems components for intravenous and blood collection systems safety and administration systems advanced injection systems and contract design and manufacturing services. The Company’s customers include producers of pharmaceuticals biologics medical devices and personal care products. The Company’s reportable segments include Pharmaceutical Packaging Systems segment (Packaging Systems) and the Pharmaceutical Delivery Systems segment (Delivery Systems).